[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JP5067529B2 - Oral composition - Google Patents

Oral composition Download PDF

Info

Publication number
JP5067529B2
JP5067529B2 JP2006335330A JP2006335330A JP5067529B2 JP 5067529 B2 JP5067529 B2 JP 5067529B2 JP 2006335330 A JP2006335330 A JP 2006335330A JP 2006335330 A JP2006335330 A JP 2006335330A JP 5067529 B2 JP5067529 B2 JP 5067529B2
Authority
JP
Japan
Prior art keywords
composition
mass
component
oil
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2006335330A
Other languages
Japanese (ja)
Other versions
JP2008143870A (en
JP2008143870A5 (en
Inventor
ゆかり 土屋
葉月 小川
昇 一ノ瀬
幸一 鈴木
憲史 徳本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lion Corp
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Priority to JP2006335330A priority Critical patent/JP5067529B2/en
Publication of JP2008143870A publication Critical patent/JP2008143870A/en
Publication of JP2008143870A5 publication Critical patent/JP2008143870A5/ja
Application granted granted Critical
Publication of JP5067529B2 publication Critical patent/JP5067529B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Cosmetics (AREA)

Description

本発明は、継続して使用しても飽きることがなく、さらに継続して使用する意向が高まる口腔用組成物に関するものである。   The present invention relates to a composition for oral cavity that does not get tired even if it is continuously used, and further increases the intention to use it continuously.

従来、う蝕又は歯周病の原因であるプラークを除去したり、口腔内の清浄化のために歯磨きや洗口剤等の口腔用組成物が用いられ、口腔ケアがなされている。しかしながら、口腔ケアは継続し習慣化してこそ意味があるものの、口腔ケアの継続によって、使用する口腔用組成物に飽きてしまい、口腔ケアの継続が中断してしまうことがある。   Conventionally, oral care such as toothpaste and mouthwash is used to remove plaque that causes caries or periodontal disease and to clean the oral cavity. However, although oral care is meaningful only if it continues and becomes a habit, continuation of oral care may get bored with the oral composition to be used, and the continuation of oral care may be interrupted.

以上のことから、口腔用組成物の使用当初の使用感にかかわらず、一定期間継続して使用しても口腔用組成物に飽きることがなく、さらに継続して使用する意向が高まり、長く使用し続けられるものが望まれていた。なお、本発明に関連する先行技術文献としては下記が挙げられる。   From the above, regardless of the initial use feeling of the oral composition, even if it is used continuously for a certain period of time, it will not get bored with the oral composition, and the intention to use it will continue to increase, and it will be used for a long time There was a need for something that could continue. In addition, the following is mentioned as a prior art document relevant to this invention.

特開平7−268851号公報JP-A-7-268851 特開2000−26260号公報JP 2000-26260 A 特開2001−19992号公報JP 2001-19992 A 特開2004−357596号公報JP 2004-357596 A 吉田倫幸、香りの心理生理作用と有用性の評価、「AROMA RESEARCH」、2001年、No.1,p38−43Noriyuki Yoshida, Evaluation of Psychophysiological Action and Usefulness of Scent, “AROMA RESEARCH”, 2001, No. 1, p38-43

本発明は上記事情に鑑みなされたもので、一定期間継続して使用しても飽きることがなく、さらに継続して使用する意向が高まり、口腔ケアを継続させ習慣化しやすくする口腔用組成物を提供することを目的とする。   The present invention has been made in view of the above circumstances, and does not get tired even if it is used continuously for a certain period of time, and further increases the intention to use it continuously. The purpose is to provide.

本発明者は、上記目的を達成するため鋭意検討した結果、カシア油、カモミール油、ナツメグ油、ジンジャー油、ウインターグリーン油、クローブ油、及びユーカリ油が、脳波と自律神経の双方に何らかの効果を与え、心理生理的効果があることを知見した。さらに、このような(A)心理的効果を与える特定の成分と、(B)刺激を与える特定の成分と、(C)苦味を有する特定の成分とを、それぞれ特定量配合し、香味面から改良することにより、一定期間継続使用しても飽きることがなく、さらに継続して使用する意向が高まること(以下、高継続使用意向と略す場合がある。)を知見し、本発明をなすに至ったものである。   As a result of intensive studies to achieve the above object, the present inventor has found that cassia oil, chamomile oil, nutmeg oil, ginger oil, wintergreen oil, clove oil, and eucalyptus oil have some effect on both the electroencephalogram and the autonomic nerve. And found that there is a psychophysiological effect. Furthermore, the specific component which gives such (A) psychological effect, (B) the specific component which gives irritation | stimulation, and the specific component which has (C) bitterness respectively mix | blends specific amount, and from a flavor side By making improvements, we know that we will not get bored even if it is used continuously for a certain period of time, and that we intend to use it further (hereinafter sometimes abbreviated as “high intention to use continuously”), and make the present invention. It has come.

従って、本発明は下記発明を提供する。
下記1)の(A)〜(C)成分の組み合わせであって、(A)成分を組成物中0.0001〜3質量%と、(B)成分を組成物中0.0005〜1質量%と、(C)成分を組成物中0.001〜3質量%とを含む口腔用組成物。
1)
(A)カシア油、カモミール油及びナツメグ油から選ばれる1種又は2種以上
(B)カプシカムオレオレジン
(C)ゲンチアナ抽出物
Accordingly, the present invention provides the following inventions.
The combination of the components (A) to (C) in the following 1), wherein the component (A) is 0.0001 to 3% by mass in the composition, and the component (B) is 0.0005 to 1% by mass in the composition. And (C) component for oral cavity containing 0.001-3 mass% in a composition.
1)
(A) One or more selected from cassia oil, chamomile oil and nutmeg oil (B) capsicum oleoresin (C) gentian extract

本発明の口腔用組成物によれば、一定期間継続使用しても飽きることがなく、さらに継続して使用する意向を高め、口腔ケアを継続させ習慣化しやすくできる。   According to the composition for oral cavity of the present invention, even if it is continuously used for a certain period of time, it does not get tired, and further, the intention to use it continuously can be increased, and oral care can be continued to make it easy to become a habit.

本発明の口腔用組成物は、下記(A)成分0.0001〜3質量%と、(B)成分0.0005〜1質量%と、(C)成分0.001〜3質量%とを含む口腔用組成物である。   The composition for oral cavity of this invention contains 0.0001-3 mass% of the following (A) component, 0.005-1 mass% of (B) component, and 0.001-3 mass% of (C) component. It is a composition for oral cavity.

(A)成分は、カシア油、カモミール油、ナツメグ油、ジンジャー油、ウインターグリーン油、クローブ油、及びユーカリ油から選ばれる1種又は2種以上である。これらの成分は、脳波(快・不快、鎮静・興奮)、及び自律神経(リラックス・活動的・興奮・嫌な感じ)のいずれにも影響を与え、心理生理的影響剤である。その測定方法については、後述の試験例において詳細に説明する。本発明においては、(A)成分の中でも、特にカシア油、カモミール油、ナツメグ油が好ましい。   The component (A) is one or more selected from cassia oil, chamomile oil, nutmeg oil, ginger oil, winter green oil, clove oil, and eucalyptus oil. These components affect any of electroencephalograms (pleasant / unpleasant, sedation / excitement) and autonomic nerves (relaxing / active / exciting / disgusting feeling) and are psychophysiological influencing agents. The measuring method will be described in detail in a test example described later. In the present invention, among the component (A), cassia oil, chamomile oil, and nutmeg oil are particularly preferable.

(A)成分の配合量は、口腔用組成物中0.0001〜3質量%であり、好ましくは0001〜0.3質量%である。(A)成分の配合量が0.0001〜3質量%の範囲外であると、高継続使用意向を示すことができない。   (A) The compounding quantity of a component is 0.0001-3 mass% in an oral cavity composition, Preferably it is 0001-0.3 mass%. When the blending amount of the component (A) is outside the range of 0.0001 to 3% by mass, it is not possible to show a high intention to use continuously.

(B)成分は、カプシカムオレオレジン、カプサイシン、ジヒドロカプサイシン、ノルジヒドロカプサイシン、ピペリン、サンショウオール、マウンテンペッパー、ジアリルジサルファイド、アリルイソチオシアネート、及びマスタードから選ばれる1種又は2種以上であり、主に刺激を与える成分である。本発明においては、(B)成分の中でも、特にカプシカムオレオレジンが好ましい。   Component (B) is one or more selected from capsicum oleoresin, capsaicin, dihydrocapsaicin, nordihydrocapsaicin, piperine, sanshool, mountain pepper, diallyl disulfide, allyl isothiocyanate, and mustard. Yes, it is a component that mainly stimulates. In the present invention, capsicum oleoresin is particularly preferable among the components (B).

(B)成分の配合量は、口腔用組成物中0.0005〜1質量%であり、好ましくは0.001〜0.5質量%である。(B)成分の配合量が0.0005〜1質量%の範囲外であると、高継続使用意向を示すことができない。   (B) The compounding quantity of a component is 0.0005-1 mass% in an oral composition, Preferably it is 0.001-0.5 mass%. When the blending amount of the component (B) is out of the range of 0.0005 to 1% by mass, it is not possible to show a high intention to continue use.

(C)キジツ抽出物、クララ抽出物、チンピ抽出物、ホップ抽出物、ジュウヤク抽出物、アルニカ抽出物、リョクチャ抽出物、ゲンチアナ抽出物、グレープフルーツ油、トラネキサム酸、塩化セチルピリジニウム、塩酸クロルヘキシジン、グルコン酸クロルヘキシジン、トリクロサン、イソプロピルメチルフェノール、カフェイン、フェノキシエタノール、及びドデシルジアミノエチルグリシンから選ばれる1種又は2種以上であり、主に苦味を有する成分である。本発明においては、(C)キジツ抽出物、クララ抽出物、チンピ抽出物、ホップ抽出物、ジュウヤク抽出物、アルニカ抽出物、リョクチャ抽出物、ゲンチアナ抽出物及びグレープフルーツ油から選ばれる1種又は2種以上を用いるものであり、特にゲンチアナ抽出物が好ましい。 (C) Pheasant extract, Clara extract, Chinpi extract, Hop extract, Jujuy extract, Arnica extract, Ryokucha extract, Gentian extract, Grapefruit oil, tranexamic acid, cetylpyridinium chloride, chlorhexidine hydrochloride, gluconic acid It is one or more selected from chlorhexidine, triclosan, isopropylmethylphenol, caffeine, phenoxyethanol, and dodecyldiaminoethylglycine, and is a component mainly having a bitter taste. In the present invention, (C) one or two selected from a pheasant extract, a clara extract, a chimpan extract, a hop extract, a juicy extract, an arnica extract, a ryokcha extract, a gentian extract and a grapefruit oil The gentian extract is particularly preferable.

(C)成分の中でも、キジツ抽出物、クララ抽出物、チンピ抽出物、ホップ抽出物、ジュウヤク抽出物、アルニカ抽出物、リョクチャ抽出物、及びゲンチアナ抽出物は、市販品あるいは公知の抽出方法よって得られたものを使用することができる。   Among the components (C), a pheasant extract, a clara extract, a chimpan extract, a hop extract, a juicy extract, an arnica extract, a ryokcha extract, and a gentian extract can be obtained by a commercially available product or a known extraction method. Can be used.

キジツ(枳実)はカン科のダイダイ、ナツダイダイ、その他同属植物の未熟果実からなる生薬である。クララ(学名:Sophora flavescens Ait)は、マメ科の多年草である。チンピ(陳皮)はミカン科のウンシュウミカンの成熟した果皮からなる生薬である。ホップはビールの原料として有名であり、アサ科の植物である。ジュウヤク(十薬)は、ドクダミ科(Sauruaceae)のドクダミ(Houttuynia cordata Thunberg)の花期の地上部からなる生薬である。アルニカは、キク科の植物アルニカの頭花から抽出されるハーブの1種である。リョクチャ(緑茶)は、茶葉を蒸して水分蒸発させ、もんで乾燥させて作る不発酵茶のことである。ゲンチアナ(学名Gentiana lutea L.)はリンドウ科に属し、根と根茎を多少発酵させて乾燥して用いる生薬である。   Pheasant is a herbal medicine consisting of immature fruits of candied daidai, natsudaidai and other related plants. Clara (scientific name: Sophora flavescens Ait) is a perennial of the legume family. Chimpi is a herbal medicine made of mature pericarp of Citrus unshiu. Hop is famous as a raw material for beer and is a plant of the family Asapaceae. Zyuyaku (ten drugs) is a herbal medicine consisting of the above-ground part of the flowering stage of Houttuynia cordata Thunberg of the Sauraceae family. Arnica is a kind of herb extracted from the flower of Arnica plant Arnica. Ryokucha (green tea) is a non-fermented tea made by steaming tea leaves to evaporate moisture and drying them. Gentiana (scientific name Gentiana lutea L.) belongs to the Gentianaceae family, and is a herbal medicine that is used after some fermentation of the roots and rhizomes and drying.

上記抽出方法に用いる溶媒としては、水;メタノール、エタノール、プロパノール、ブタノール等のアルコール類;プロピレングリコール、ブチレングリコール等の多価アルコール類等が挙げられ、これらを単独で又は2種以上の混合溶媒として用いることができる。   Examples of the solvent used in the extraction method include water; alcohols such as methanol, ethanol, propanol, and butanol; polyhydric alcohols such as propylene glycol and butylene glycol, and the like. These may be used alone or in combination of two or more. Can be used as

上記抽出方法における各種条件は、特に制限されるものではないが、通常、抽出原料と上記抽出溶媒との比率は、質量比で抽出原料:抽出溶媒=1:2〜1:50程度の範囲が好ましい。また、抽出温度は、5〜80℃の範囲が好ましく、1時間〜1週間、抽出溶媒に浸漬したり、攪拌したりすることによって行うことが好ましい。なお、抽出pHは、極端な酸性又はアルカリ性でなければ、特に制限はない。   Various conditions in the extraction method are not particularly limited, but the ratio of the extraction raw material to the extraction solvent is usually in a range of about 1: 2 to 1:50 extraction raw material: extraction solvent = 1: 50 by mass ratio. preferable. The extraction temperature is preferably in the range of 5 to 80 ° C., and is preferably performed by immersing or stirring in the extraction solvent for 1 hour to 1 week. The extraction pH is not particularly limited as long as it is not extremely acidic or alkaline.

上記抽出溶媒が、水、エタノール、水/エタノール(含水エタノール)等の非毒性の溶媒である場合は、抽出物をそのまま用いても良く、あるいは希釈液として用いてもよい。また、上記抽出物を濃縮エキスとしてもよく、凍結乾燥等により乾燥粉末物にしたり、ペースト状に調製したりしてもよい。なお、他の溶媒を用いた場合は、溶媒を留去後、乾燥分を非毒性の溶媒で希釈して用いることが好ましい。   When the extraction solvent is a non-toxic solvent such as water, ethanol, water / ethanol (hydrous ethanol), the extract may be used as it is or as a diluent. Moreover, the said extract may be used as a concentrated extract, and may be made into a dry powder by freeze drying or the like, or may be prepared in a paste form. When other solvents are used, it is preferable to distill the solvent and dilute the dried portion with a non-toxic solvent.

(C)成分の配合量は、口腔用組成物中0.001〜3質量%であり、好ましくは0.01〜1.5質量%である。(B)成分の配合量が0.001〜3質量%の範囲外であると、高継続使用意向を示すことができない。   (C) The compounding quantity of a component is 0.001-3 mass% in an oral cavity composition, Preferably it is 0.01-1.5 mass%. When the blending amount of the component (B) is outside the range of 0.001 to 3% by mass, it is not possible to indicate a high continuous use intention.

本発明の口腔用組成物には、上記(A)〜(C)成分の他に、口腔用組成物に使用可能な任意成分を添加することができる。具体的に保湿剤として、グリセリン、ソルビット、プロピレングリコール、ポリエチレングリコール等の多価アルコール、界面活性剤としてラウリル硫酸ナトリウム等のアニオン界面活性剤、ラウリン酸デカグリセリル、ポリオキシエチレン硬化ヒマシ油、ミリスチン酸ジエタノールアミド等の非イオン界面活性剤、有効成分としてフッ化ナトリウム等のフッ化物、デキストラナーゼ、ムタナーゼ等の酵素、トラネキサム酸、ε−アミノカプロン酸等、香味剤としてはサッカリンナトリウム、メントール、ペパーミント、スペアミント等が挙げられる。なお、これら任意成分の配合量は、本発明の効果を妨げない範囲で有効量とすることができる。   In addition to the components (A) to (C), an optional component that can be used for the oral composition can be added to the oral composition of the present invention. Specific examples of moisturizing agents include polyhydric alcohols such as glycerin, sorbit, propylene glycol, and polyethylene glycol, surfactants such as anionic surfactants such as sodium lauryl sulfate, decaglyceryl laurate, polyoxyethylene hydrogenated castor oil, and myristic acid. Nonionic surfactants such as diethanolamide, fluorides such as sodium fluoride as active ingredients, enzymes such as dextranase and mutanase, tranexamic acid, ε-aminocaproic acid, etc., saccharin sodium, menthol, peppermint, spearmint as flavoring agents Etc. In addition, the compounding quantity of these arbitrary components can be made into an effective quantity in the range which does not prevent the effect of this invention.

本発明の口腔用組成物は、上記必須成分、任意成分、及び水(口腔用組成物が100質量%となるように残部配合)を混合し、常法によって得ることができる。   The oral composition of the present invention can be obtained by a conventional method by mixing the above-mentioned essential components, optional components, and water (the remainder blended so that the oral composition is 100% by mass).

本発明の口腔用組成物は、歯磨き、洗口剤として用いることができ、洗口剤として好適である。その剤型としては、液体、軟膏、ペースト、ゲル、ゾル、クリーム等に調製することができるが、液体が好ましい。   The composition for oral cavity of this invention can be used as a toothpaste and a mouthwash, and is suitable as a mouthwash. The dosage form can be prepared as a liquid, ointment, paste, gel, sol, cream, etc., but liquid is preferred.

本発明の口腔用組成物は、一定期間(14日以上程度)継続使用しても飽きることがなく、さらに継続して使用する意向を高め、口腔ケアを継続させ習慣化しやすくすることができる。   The composition for oral cavity of the present invention does not get tired even if it is continuously used for a certain period (about 14 days or more), further increases the intention to use it continuously, makes it possible to continue oral care and make it easy to become a habit.

以下、実施例及び比較例を示し、本発明を具体的に説明するが、本発明は下記の実施例に制限されるものではない。なお、下記の例において特に明記のない場合は、組成の「%」は質量%を示す。   EXAMPLES Hereinafter, although an Example and a comparative example are shown and this invention is demonstrated concretely, this invention is not restrict | limited to the following Example. In the following examples, unless otherwise specified, “%” in the composition represents mass%.

[試験例]
カモミール油、カシア油、ユーカリ油、ウインターグリーン油、ナツメグ油、クローブ油、ジンジャー油、タイムホワイト油、及びシソ油について、下記方法で洗口剤を調製し、この洗口剤を用い被験者8人で、下記方法に基づいて心理生理的効果を評価した。結果を表4に示す。
[Test example]
For chamomile oil, cassia oil, eucalyptus oil, winter green oil, nutmeg oil, clove oil, ginger oil, thyme white oil, and perilla oil, a mouthwash was prepared by the following method, and 8 subjects used this mouthwash. The psychophysiological effects were evaluated based on the following method. The results are shown in Table 4.

洗口剤の調製
カモミール油、カシア油、ウインターグリーン油、ユーカリ油、ナツメグ油、クローブ油、ジンジャー油、タイムホワイト油、及びシソ油をそれぞれ単独で0.1部、以下の洗口剤基剤99.9部に添加し、撹拌溶解させ洗口剤を得た。
洗口剤基剤 組成(%)
クエン酸 0.03
クエン酸ソーダ 0.25
安息香酸ソーダ 0.30
ソルビトール 0.70
グリセリン 1.00
プロピレングリコール 0.50
メチルパラベン 0.10
HCO60 1.00
(ポリオキシエチレン硬化ヒマシ油)
精製水 96.02
合計 99.9
Preparation of mouthwash Chamomile oil, cassia oil, winter green oil, eucalyptus oil, nutmeg oil, clove oil, ginger oil, thyme white oil and perilla oil alone, 0.1 parts each, the following mouthwash base It was added to 99.9 parts and dissolved by stirring to obtain a mouthwash.
Mouthwash base composition (%)
Citric acid 0.03
Sodium citrate 0.25
Sodium benzoate 0.30
Sorbitol 0.70
Glycerin 1.00
Propylene glycol 0.50
Methylparaben 0.10
HCO 60 1.00
(Polyoxyethylene hydrogenated castor oil)
Purified water 96.02
Total 99.9

(1)脳波計測
102.4秒間の脳波計測を連続して5回行った。2回目の計測時間中に開眼して、洗口剤20mLを20秒間口に含み、吐き出した。この洗口剤使用時以外は安静閉眼状態とした。洗口剤を使用する前の第1回計測を洗口剤使用前、第2回計測を洗口剤使用中、第3〜5回計測を洗口剤使用後とした。
)。
(1) Brain wave measurement The brain wave measurement for 102.4 seconds was performed 5 times continuously. During the second measurement time, the eyes were opened, and 20 mL of mouthwash was contained in the mouth for 20 seconds, and then discharged. Except when this mouthwash was used, the eyes were rested and closed. The first measurement before using the mouthwash was made before using the mouthwash, the second measurement was made while using the mouthwash, and the third to fifth measurements were made after using the mouthwash.
).

簡易型α波周波数リズム測定機(ひとセンシング(株)製)を用いて、被験者の脳波を計測した。計測は電極を国際10−20法に従いFp1とFp2の前頭部2部位に装着し、右耳朶をアース、左耳朶を基準電極として前頭部脳波(8〜13Hz)を記録した。記録された脳波の左右それぞれの周波数と時間的変動(ゆらぎ)の解析を行い、吉田教授の理論(参考文献:吉田倫幸、「香りの心理生理作用と有用性の評価」AROMA RESEARCH No.1,38−43(2001))に基づき、生理状態と心理状態を確認した。すなわち左右の脳波の周波数から脳活動度(周波数増加→覚醒状態への推移、周波数減少→睡眠状態への推移)という生理状態を求め、左右の脳波のゆらぎからそれぞれ左リズム度;快−不快、右リズム度;鎮静−興奮という心理学的な2軸における気分の程度と総合的な心理状態を求めた。
評価は洗口剤使用前をブランクとし、使用前に対する「使用中から使用後」の脳活動度と心理状態の変化から効果を判断した。
The subject's brain waves were measured using a simple α-wave frequency rhythm measuring machine (manufactured by Human Sensing Co., Ltd.). For measurement, electrodes were attached to two frontal regions of Fp1 and Fp2 according to the International 10-20 method, and frontal brain waves (8 to 13 Hz) were recorded using the right earlobe as the ground and the left earlobe as the reference electrode. The left and right frequencies and temporal variations (fluctuations) of the recorded brain waves were analyzed, and Professor Yoshida's theory (reference: Yoshiyuki Yoshida, “Evaluation of psychophysiological effects and usefulness of fragrances”, AROMA RESEARCH No. 1, 38-43 (2001)), the physiological state and the psychological state were confirmed. That is, the physiological state of brain activity (frequency increase → transition to arousal state, frequency decrease → transition to sleep state) is obtained from the frequency of the left and right brain waves, and the left rhythm degree from the fluctuations of the left and right brain waves; The degree of right rhythm; sedation-excited psychological degree in two axes and the overall psychological state.
The evaluation was performed using a blank before using the mouthwash, and the effect was judged from changes in brain activity and psychological state "from use to use" compared to before use.

脳活動度については、
[使用中から使用後の活動度の平均値−使用前の活動度]>0となった被験者の数を指標とし、以下の判定基準に基づいて評価した。
About brain activity,
[Average value of activity after use-activity before use-activity before use]> The number of subjects who became 0 was used as an index and evaluated based on the following criteria.

Figure 0005067529
Figure 0005067529

心理状態については、下記の左右リズム度から総合的に判断した。

Figure 0005067529
About the psychological state, it judged comprehensively from the following right-and-left rhythm degree.
Figure 0005067529

(2)心電図測定
3分間の装置アイドリングの後、上記(1)脳波計測5回分の時間に合わせ、連続で6分50秒間行った。洗口剤使用前、使用中、及び使用後のタイミングは脳波計測に準拠し、測定後にそれぞれの区間のデータを独立して解析した。
(2) Electrocardiogram measurement After apparatus idling for 3 minutes, the measurement was continuously performed for 6 minutes and 50 seconds in accordance with the time for the above (1) brain wave measurement. The timing before, during and after use of the mouthwash was based on electroencephalogram measurement, and the data of each section were analyzed independently after the measurement.

循環動態波形・ゆらぎ解析ソフトウェア フラクレットWT(大日本製薬(株)製)を用いて、被験者の心電図を測定した。測定は心臓を対角線で挟むように右胸上部にマイナス電極、左胸下部にプラス電極を装着し、また左胸上部にアース電極を装着して行った。心電図のシグナルの波形を基に心拍のゆらぎを解析し、自律神経(交感神経と副交感神経)の活動度を求めた。
評価は洗口剤使用前をブランクとし、使用前に対する「使用中から使用後」の自律神経活動度の変化から効果を判断した。
The electrocardiogram of the subject was measured using a circulatory dynamic waveform / fluctuation analysis software Fraclet WT (Dainippon Pharmaceutical Co., Ltd.). The measurement was performed with a negative electrode on the upper right chest, a positive electrode on the lower left chest, and a ground electrode on the upper left chest so that the heart is sandwiched diagonally. Heart rate fluctuations were analyzed based on the ECG signal waveform to determine the activity of autonomic nerves (sympathetic and parasympathetic).
In the evaluation, the mouthwash before use was blank, and the effect was judged from the change in autonomic nerve activity from “in use to after use” with respect to before use.

すなわち交感神経又は副交感神経の活動度の[使用中から使用後の平均値)−(使用前の平均値]>0となった被験者の数を指標とし、以下の判定基準に基づいて評価した。また、自律神経系のバランスを交感神経及び副交感神経の活動度から判断し、自律神経系解析結果(バランス)として併記した。   That is, evaluation was performed based on the following criteria, using as an index the number of subjects whose [symmetry nerve or parasympathetic nerve activity [average value after use to after use] − (average value before use]> 0). In addition, the balance of the autonomic nervous system was judged from the activity of the sympathetic nerve and the parasympathetic nerve, and was also written as the autonomic nervous system analysis result (balance).

Figure 0005067529
Figure 0005067529

Figure 0005067529
Figure 0005067529

カモミール油、カシア油、ユーカリ油、ウインターグリーン油、ナツメグ油、クローブ油、及びジンジャー油については、脳波及び自律神経の双方に影響を与え、心理生理的影響力を有するものであった。   Chamomile oil, cassia oil, eucalyptus oil, winter green oil, nutmeg oil, clove oil, and ginger oil affected both the electroencephalogram and autonomic nerve, and had psychophysiological influence.

[実施例1〜18、参考例1〜8、比較例1〜17]
表5〜12に示す組成の洗口剤を調製し、下記方法で使用意向を評価した。結果を表中に併記する。
[Examples 1 to 18, Reference Examples 1 to 8, Comparative Examples 1 to 17]
Mouthwashes having the compositions shown in Tables 5 to 12 were prepared, and the intention to use was evaluated by the following methods. The results are also shown in the table.

<使用意向評価方法>
洗口剤を被験者33名にそれぞれ1日2回、1回に10mLずつ2週間連続使用させ、その初回使用時及び2週間後(終了時)の2回、継続して使用したいか否かを下記判定基準で評価した。結果を33名の平均値で示す。
使用意向の判定基準
7;非常に使いたい
6;かなり使いたい
5;やや使いたい
4;どちらでもない
3;やや使いたくない
2;かなり使いたくない
1;非常に使いたくない
<Intended use evaluation method>
Whether or not you want to continue using mouthwashes for 33 subjects each time, twice a day, 10 mL each time for 2 weeks, 2 times after the first use and 2 weeks later (when finished) The following criteria were used for evaluation. A result is shown by the average value of 33 persons.
Judgment Criteria for Use Intention 7; Very Wanted 6; Pretty Wanted 5; Somewhat Wanted 5; Somewhat Wanted 4; Neither Wanted 3; Somewhat Not Wanted 2; Somewhat Not Wanted 1;

下記の式から各々の試料の連続使用による使用意向変化率(%)を求めた。
連続使用による使用意向変化率(%)
=[(2週間連続使用後の使用意向の平均値)−(初回の使用意向の平均値)]/
(初回の使用意向の平均値)×100
From the following formula, the change in intention to use (%) by continuous use of each sample was determined.
Rate of change in intention to use due to continuous use (%)
= [(Average value of intention to use after 2 weeks of continuous use)-(Average value of intention to use for the first time)] /
(Average value of initial intention to use) x 100

Figure 0005067529
Figure 0005067529

Figure 0005067529
Figure 0005067529

Figure 0005067529
Figure 0005067529

Figure 0005067529
Figure 0005067529

Figure 0005067529
Figure 0005067529

Figure 0005067529
Figure 0005067529

Figure 0005067529
Figure 0005067529

Figure 0005067529
Figure 0005067529

上記結果によれば、本発明の口腔用組成物は2週間連続使用後の「使用意向」が高く、使用意向変化率が正の方向に高く、連続使用により嗜好性が上昇した。   According to the above results, the composition for oral cavity of the present invention had a high “intention to use” after continuous use for 2 weeks, a high change in the intent to use, and the preference increased with continuous use.

Claims (11)

下記1)の(A)〜(C)成分の組み合わせであって、(A)成分を組成物中0.0001〜3質量%と、(B)成分を組成物中0.0005〜1質量%と、(C)成分を組成物中0.001〜3質量%とを含む口腔用組成物。
1)
(A)カシア油、カモミール油及びナツメグ油から選ばれる1種又は2種以上
(B)カプシカムオレオレジン
(C)ゲンチアナ抽出物
The combination of the components (A) to (C) in the following 1), wherein the component (A) is 0.0001 to 3% by mass in the composition, and the component (B) is 0.0005 to 1% by mass in the composition. And (C) component for oral cavity containing 0.001-3 mass% in a composition.
1)
(A) One or more selected from cassia oil, chamomile oil and nutmeg oil (B) capsicum oleoresin (C) gentian extract
下記2)の(A)〜(C)成分の組み合わせであって、(A)成分を組成物中0.0001〜3質量%と、(B)成分を組成物中0.0005〜1質量%と、(C)成分を組成物中0.001〜3質量%とを含む口腔用組成物。
2)
(A)カシア油、ナツメグ油及びジンジャー油から選ばれる1種又は2種以上
(B)アリルイソチオシアネート
(C)ジュウヤク抽出物から選ばれる1種又は2種以上とを含む口腔用組成物。
The combination of the components (A) to (C) in the following 2), wherein the component (A) is 0.0001 to 3% by mass in the composition, and the component (B) is 0.0005 to 1% by mass in the composition. And (C) component for oral cavity containing 0.001-3 mass% in a composition.
2)
(A) 1 type, or 2 or more types chosen from cassia oil, nutmeg oil, and ginger oil (B) allyl isothiocyanate (C) 1 type, or 2 or more types chosen from a jujube extract.
下記3)〜5)から選ばれる(A)〜(C)成分の組み合わせであって、(A)成分を組成物中0.0001〜3質量%と、(B)成分を組成物中0.0005〜1質量%と、(C)成分を組成物中0.001〜3質量%とを含む口腔用組成物。
3)
(A)カシア油及びカモミール油から選ばれる1種又は2種以上
(B)ジヒドロカプサイシン及びマスタードから選ばれる1種又は2種以上
(C)リョクチャ抽出物
4)
(A)カシア油及びカモミール油から選ばれる1種又は2種以上
(B)アリルイソチオシアネート及びマスタードから選ばれる1種又は2種以上
(C)ゲンチアナ抽出物
5)
(A)カシア油及びカモミール油から選ばれる1種又は2種以上
(B)ノルジヒドロカプサイシン、マウンテンペッパー及びサンショウオールから選ばれる1種又は2種以上
(C)チンピ抽出物
The combination of the components (A) to (C) selected from the following 3) to 5), wherein the component (A) is 0.0001 to 3% by mass in the composition, and the component (B) is 0.00 in the composition. The composition for oral cavity containing 0005-1 mass% and 0.001-3 mass% in (C) component in a composition.
3)
(A) One or more selected from cassia oil and chamomile oil (B) One or more selected from dihydrocapsaicin and mustard (C) Ryokucha extract 4)
(A) One or more selected from cassia oil and chamomile oil (B) One or more selected from allyl isothiocyanate and mustard (C) Gentian extract 5)
(A) One or more kinds selected from cassia oil and chamomile oil (B) One or more kinds selected from nordihydrocapsaicin, mountain pepper and sanshool (C) Chinpi extract
下記6)の(A)〜(C)成分の組み合わせであって、(A)成分を組成物中0.0001〜3質量%と、(B)成分を組成物中0.0005〜1質量%と、(C)成分を組成物中0.001〜3質量%とを含む口腔用組成物。
6)
(A)ナツメグ油及びジンジャー油から選ばれる1種又は2種以上
(B)カプシカムオレオレジン及びジヒドロカプサイシンから選ばれる1種又は2種以上
(C)ジュウヤク抽出物及びアルニカ抽出物から選ばれる1種又は2種以上
The combination of the components (A) to (C) in the following 6), wherein the component (A) is 0.0001 to 3% by mass in the composition, and the component (B) is 0.0005 to 1% by mass in the composition. And (C) component for oral cavity containing 0.001-3 mass% in a composition.
6)
(A) One or more selected from nutmeg oil and ginger oil (B) One or more selected from capsicum oleoresin and dihydrocapsaicin (C) Selected from juyaku extract and arnica extract 1 type or 2 types or more
下記7)の(A)〜(C)成分の組み合わせであって、(A)成分を組成物中0.0001〜3質量%と、(B)成分を組成物中0.0005〜1質量%と、(C)成分を組成物中0.001〜3質量%とを含む口腔用組成物。
7)
(A)カシア油
(B)カプサイシン、マウンテンペッパー及びマスタードから選ばれる1種又は2種以上(C)クララ抽出物、チンピ抽出物及びゲンチアナ抽出物から選ばれる1種又は2種以上
The combination of the components (A) to (C) of the following 7), wherein the component (A) is 0.0001 to 3% by mass in the composition, and the component (B) is 0.0005 to 1% by mass in the composition. And (C) component for oral cavity containing 0.001-3 mass% in a composition.
7)
(A) Cassia oil (B) One or more selected from capsaicin, mountain pepper and mustard (C) One or more selected from Clara extract, Chinpi extract and Gentian extract
下記8)又は9)の(A)〜(C)成分の組み合わせであって、(A)成分を組成物中0.0001〜3質量%と、(B)成分を組成物中0.0005〜1質量%と、(C)成分を組成物中0.001〜3質量%とを含む口腔用組成物。
8)
(A)ナツメグ油
(B)アリルイソチオシアネート
(C)グレープフルーツ油
9)
(A)ナツメグ油
(B)カプシカムオレオレジン及びマスタードから選ばれる1種又は2種以上
(C)クララ抽出物及びグレープフルーツ油から選ばれる1種又は2種以上
The combination of the components (A) to (C) of the following 8) or 9), wherein the component (A) is 0.0001 to 3% by mass in the composition, and the component (B) is 0.0005 to 0.0005 in the composition. The composition for oral cavity containing 1 mass% and 0.001-3 mass% in (C) component in a composition.
8)
(A) Nutmeg oil (B) Allyl isothiocyanate (C) Grapefruit oil 9)
(A) Nutmeg oil (B) One or more selected from capsicum oleoresin and mustard (C) One or more selected from Clara extract and grapefruit oil
下記10)の(A)〜(C)成分の組み合わせであって、(A)成分を組成物中0.0001〜3質量%と、(B)成分を組成物中0.0005〜1質量%と、(C)成分を組成物中0.001〜3質量%とを含む口腔用組成物。
10)
(A)カモミール油
(B)マウンテンペッパー
(C)クララ抽出物
The combination of the components (A) to (C) of 10) below, wherein the component (A) is 0.0001 to 3% by mass in the composition, and the component (B) is 0.0005 to 1% by mass in the composition. And (C) component for oral cavity containing 0.001-3 mass% in a composition.
10)
(A) Chamomile oil (B) Mountain pepper (C) Clara extract
下記11)の(A)〜(C)成分の組み合わせであって、(A)成分を組成物中0.0001〜3質量%と、(B)成分を組成物中0.0005〜1質量%と、(C)成分を組成物中0.001〜3質量%とを含む口腔用組成物。
11)
(A)ジンジャー油
(B)マウンテンペッパー及びアリルイソチオシアネート
(C)グレープフルーツ油
11) The combination of the components (A) to (C) below, wherein the component (A) is 0.0001 to 3% by mass in the composition, and the component (B) is 0.0005 to 1% by mass in the composition. And (C) component for oral cavity containing 0.001-3 mass% in a composition.
11)
(A) Ginger oil (B) Mountain pepper and allyl isothiocyanate (C) Grapefruit oil
下記12)の(A)〜(C)成分の組み合わせであって、(A)成分を組成物中0.0001〜3質量%と、(B)成分を組成物中0.0005〜1質量%と、(C)成分を組成物中0.001〜3質量%とを含む口腔用組成物。
12)
(A)カシア油及びナツメグ油から選ばれる1種又は2種以上
(B)カプシカムオレオレジン
(C)ゲンチアナ抽出物
The combination of the components (A) to (C) in the following 12), wherein the component (A) is 0.0001 to 3% by mass in the composition, and the component (B) is 0.0005 to 1% by mass in the composition. And (C) component for oral cavity containing 0.001-3 mass% in a composition.
12)
(A) One or more selected from cassia oil and nutmeg oil (B) Capsicum oleoresin (C) Gentian extract
さらに、トラネキサム酸、塩酸クロルヘキシジン、グルコン酸クロルヘキシジン、トリクロサン、イソプロピルメチルフェノール、カフェイン、フェノキシエタノール、及びドデシルジアミノエチルグリシンから選ばれる1種又は2種以上を含む請求項1〜9のいずれか1項記載の口腔用組成物。   Furthermore, 1 type or 2 or more types chosen from tranexamic acid, chlorhexidine hydrochloride, chlorhexidine gluconate, triclosan, isopropylmethylphenol, caffeine, phenoxyethanol, and dodecyl diaminoethyl glycine of any one of Claims 1-9. Oral composition. 液体の洗口剤である請求項1〜10のいずれか1項記載の口腔用組成物。   It is a liquid mouthwash, The composition for oral cavity of any one of Claims 1-10.
JP2006335330A 2006-12-13 2006-12-13 Oral composition Active JP5067529B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006335330A JP5067529B2 (en) 2006-12-13 2006-12-13 Oral composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006335330A JP5067529B2 (en) 2006-12-13 2006-12-13 Oral composition

Publications (3)

Publication Number Publication Date
JP2008143870A JP2008143870A (en) 2008-06-26
JP2008143870A5 JP2008143870A5 (en) 2011-05-26
JP5067529B2 true JP5067529B2 (en) 2012-11-07

Family

ID=39604442

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006335330A Active JP5067529B2 (en) 2006-12-13 2006-12-13 Oral composition

Country Status (1)

Country Link
JP (1) JP5067529B2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8962057B2 (en) * 2009-04-29 2015-02-24 The Procter & Gamble Company Methods for improving taste and oral care compositions with improved taste
MY152711A (en) * 2009-12-04 2014-11-28 Colgate Palmolive Co Oral compositions containing a combination of natural extracts and related methods
MY150829A (en) * 2009-12-04 2014-02-28 Colgate Palmolive Co Oral compositions containing extracts of myristica fragrans and related methods
US20120244086A1 (en) * 2009-12-04 2012-09-27 Colgate-Palmolive Company Oral compositions containing extracts of zingiber officinale and related methods
JP5897843B2 (en) * 2011-08-11 2016-03-30 株式会社ロッテ Composition for oral cavity containing spice extract
JP5748626B2 (en) * 2011-09-21 2015-07-15 サンスター株式会社 Oral composition
JP6249588B2 (en) * 2011-09-30 2017-12-20 小林製薬株式会社 Oral composition
JP6111981B2 (en) * 2013-10-30 2017-04-12 ライオン株式会社 Liquid oral composition
CN108969413A (en) * 2017-06-05 2018-12-11 狮王株式会社 Composition for oral cavity
JP7031253B2 (en) * 2017-11-29 2022-03-08 ライオン株式会社 Toothpaste composition
JP2019112329A (en) 2017-12-22 2019-07-11 ライオン株式会社 Oral cavity composition and discoloration suppression method thereof
WO2021062607A1 (en) * 2019-09-30 2021-04-08 The Procter & Gamble Company Oral care compositions comprising hops beta acid and amino acid
CN114449996B (en) 2019-09-30 2024-10-01 宝洁公司 Oral care compositions comprising hops beta acids and metal ions
GB2590973B (en) * 2020-01-10 2022-01-12 Diet Shield Ltd Composition comprising a lip interacting component
BR112022016384A2 (en) 2020-02-18 2022-10-11 Sunstar Americas Inc ORAL CARE COMPOSITION
WO2024096835A1 (en) * 2022-11-01 2024-05-10 Istanbul Medipol Universitesi Oral care preparations comprising a combination of standardized essential oils and antiseptic agents
CN116327675B (en) * 2023-05-19 2024-09-24 山东大学 Herbal mouthwash containing lactobacillus sanfranciscensis and preparation method thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2098476B (en) * 1981-05-13 1984-10-31 Colgate Palmolive Co Flavoured aqueous oral composition
JPS61155315A (en) * 1984-12-28 1986-07-15 Lion Corp Composition for oral purpose
JPH09104891A (en) * 1995-10-09 1997-04-22 Lion Corp Perfumery composition
JP3613631B2 (en) * 1999-03-31 2005-01-26 サンスター株式会社 Oral liquid composition
JP2004018431A (en) * 2002-06-14 2004-01-22 Kiyomitsu Kawasaki Perfume composition for oral cavity and oral cavity composition containing the same
CN101010091A (en) * 2004-09-02 2007-08-01 宝洁公司 Oral care composition comprising essential oils
JP4883895B2 (en) * 2004-09-30 2012-02-22 小川香料株式会社 Flavoring composition
EP1874132A1 (en) * 2005-04-15 2008-01-09 Firmenich Sa Hot flavour and skin sensation composition

Also Published As

Publication number Publication date
JP2008143870A (en) 2008-06-26

Similar Documents

Publication Publication Date Title
JP5067529B2 (en) Oral composition
KR101448283B1 (en) A Composition of a Bubble Dentifrice and the Method of Making it
KR101955468B1 (en) Preparing method for toothpaste composition comprising natural extracts
JP2004083443A (en) Composition using mastic for preventing and treating periodontal disease and method for preventing and treating periodontal disease
EP2716303A1 (en) Psychic energizer agent and psychic energizer composition
JP2011126818A (en) Dentifrice composition
JP2003081800A (en) Anti-periodontitis agent
JP2004520304A (en) Oral composition for suppressing bad breath
JP2681081B2 (en) Mouthwash composition for hyperesthesia
JPH11255636A (en) Blood circulation promoter
JPH0853327A (en) Hair tonic composed of allantoin or its derivative
KR102597516B1 (en) Fragrance composition for stress relief and psychological stability enhancement containing novel organic compounds as active ingredients
JPH0525849B2 (en)
JP3534959B2 (en) Hair restoration cosmetics
KR101321045B1 (en) Composition of preventing hair loss and promoting hair growth
KR102816654B1 (en) Composition for scalp cleansing and method for producing the same
JPH08291018A (en) Humectant for cosmetic
JP7567791B2 (en) Composition for oral cavity and agent for providing massage sensation to gums
JP2005162633A (en) Salivation promoter, and oral cavity composition and food composition containing the same
KR101287800B1 (en) Oral composition
JP7403736B2 (en) Oral composition
JP7508243B2 (en) Oral Composition
JP7672414B2 (en) Liquid oral composition
DE68914451T2 (en) ORAL SUPPLIES.
JP2024093493A (en) Dentifrice composition

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20091201

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110412

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20110928

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111019

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111216

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120718

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120731

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150824

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 5067529

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350